Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 Hydrodissection for Carpal Tunnel Syndrome
NCT03802422Withdrawn
- Sponsor
- Tri-Service General Hospital
- Start
- Apr 2019
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of mecobalamin in carpal tunnel syndrome (CTS) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Boston Carpal Tunnel Syndrome Questionnaire at 6 months. Planned start Apr 2019; status: withdrawn.
02
Drugs
mecobalamin
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT03802422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802422.